Habronema muscae in Horses: Stomach Worms and Cutaneous Habronemiasis (Summer Sores)

1. Introduction and Etiological Classification

Habronema muscae (Carter, 1861) is a spirurid nematode belonging to the family Habronematidae within the order Spirurida [1]. This parasite is a primary etiological agent of equine gastric habronemiasis and cutaneous habronemiasis, the latter commonly termed "summer sores" [2, 3]. The genus Habronema includes two other species infecting equids: Habronema microstoma and Habronema megastoma (now often reclassified as Draschia megastoma), though H. muscae is the most frequently implicated species in cutaneous pathology [2, 4]. The parasite is distributed globally, with prevalence rates varying by climate, management practices, and the abundance of its intermediate host, the housefly (Musca domestica) [5, 6, 7, 8].

2. Morphology and Life Cycle

2.1 Adult Morphology

Adult H. muscae are slender, whitish nematodes inhabiting the equine stomach [1]. Males measure 9 to 16 mm in length, while females range from 15 to 25 mm [1]. The anterior end is characterized by two lateral lips, each bearing a pair of papillae, and a prominent buccal capsule [1]. The caudal end of the male possesses well-developed caudal alae supported by four pairs of pedunculated papillae, a feature critical for species identification [1]. Scanning electron microscopy (SEM) has revealed detailed cuticular ornamentation, including transverse striations and the precise arrangement of phasmids and amphids [1].

2.2 Life Cycle

The life cycle of H. muscae is indirect, requiring a dipteran intermediate host [9, 10]. Adult females in the equine stomach produce embryonated eggs that are shed into the environment via feces [9, 11]. The eggs are ingested by larval stages of M. domestica [9]. Within the fly larva, the eggs hatch and develop through two molts to the infective third-stage (L3) larva [9, 12]. This development is temperature-dependent, with optimal maturation occurring at 25 to 30 degrees Celsius [9]. The L3 larvae migrate to the head and proboscis of the adult fly, where they are positioned for transmission [12].

When the infected fly lands on the moist skin or mucous membranes of a horse, particularly around the lips, eyes, or wounds, the L3 larvae are deposited [12, 10]. If deposited on the skin, they penetrate the epidermis and initiate cutaneous habronemiasis [10]. If ingested, the larvae exsheath in the mouth, migrate to the stomach, and molt to the fourth-stage (L4) and then adult stage within the gastric mucosa [9, 11]. The prepatent period is approximately 8 to 10 weeks [11].

graph TD
    A[Adult H. muscae in equine stomach] --> B[Eggs shed in feces]
    B --> C[Eggs ingested by M. domestica larvae]
    C --> D[L1 to L3 development in fly]
    D --> E[L3 migrate to fly proboscis]
    E --> F[L3 deposited on horse skin/mucosa]
    F --> G["Ingestion: L3 to stomach, adult"]
    F --> H["Cutaneous penetration: L3 to wound"]
    H --> I["Granulomatous lesion: summer sore"]
    G --> J["Adult in stomach: egg production"]
    J --> B

3. Pathogenesis and Clinical Disease

3.1 Gastric Habronemiasis

Gastric habronemiasis is caused by adult H. muscae and H. microstoma embedded in the gastric mucosa [11, 6]. The nematodes induce a chronic eosinophilic and granulomatous inflammation, often resulting in nodular lesions, particularly along the margo plicatus [6, 7]. These lesions can become fibrotic and may obstruct the pyloric region in heavy infestations [6]. Clinical signs are often subclinical but can include weight loss, poor condition, and intermittent colic [6, 7]. The presence of H. muscae is frequently identified at necropsy, with prevalence rates of 20 to 80% in some populations [6, 7, 8].

3.2 Cutaneous Habronemiasis (Summer Sores)

Cutaneous habronemiasis is a seasonal, proliferative, granulomatous dermatitis caused by the aberrant deposition and development of H. muscae L3 larvae in the skin [13, 14, 15]. The condition is most prevalent in warm, wet months when fly populations are high [13, 16]. Lesions typically occur on the medial canthus of the eye, the prepuce, penis, and the distal limbs [13, 17, 15]. They are characterized by exuberant granulation tissue, a serosanguinous exudate, and the presence of small, yellow, calcified "sulfur granules" within the tissue [13, 3].

Histopathologically, lesions show a severe eosinophilic and mast cell infiltrate, with necrotic foci surrounded by epithelioid macrophages and multinucleated giant cells [3, 18]. The L3 larvae are often found within these granulomas, surrounded by a zone of Splendore-Hoeppli material [3]. The condition is intensely pruritic, leading to self-trauma and secondary bacterial infection [13, 15].

3.3 Conjunctival and Ocular Habronemiasis

Ocular habronemiasis presents as a chronic, proliferative conjunctivitis, often affecting the medial canthus [13, 15]. Lesions are similar to cutaneous forms, with granulation tissue and a mucopurulent discharge [15]. This form can lead to corneal ulceration and secondary bacterial keratitis if left untreated [15].

3.4 Pulmonary Habronemiasis

Rarely, L3 larvae can be aspirated or migrate to the lungs, causing pulmonary granulomas [10]. This has been documented in cases of heavy fly infestation in confined stables [10].

4. Molecular Diagnostics and Laboratory Identification

4.1 Coprological Diagnosis

Gastric habronemiasis is diagnosed by the detection of characteristic eggs in feces using flotation techniques [11, 19]. The eggs are thick-shelled, embryonated, and measure 40 to 50 micrometers by 10 to 12 micrometers [11]. However, fecal egg counts can be unreliable due to intermittent shedding and the low sensitivity of flotation methods [19].

4.2 Molecular Diagnostics

Polymerase chain reaction (PCR) has become the gold standard for species-specific identification of H. muscae [2, 19, 4, 20]. A semi-nested PCR targeting the internal transcribed spacer 2 (ITS-2) region of ribosomal DNA has been developed for the specific detection of H. muscae and H. microstoma in fecal samples [19, 4]. This assay has a sensitivity of 90 to 95% and a specificity of 100% when validated against morphologically identified specimens [19, 4].

A more recent diagnostic approach uses real-time PCR (qPCR) targeting the cytochrome c oxidase subunit I (COI) gene, which allows for quantification of parasite DNA and differentiation between H. muscae and H. microstoma [20]. This method also enables the assessment of gene expression levels, providing insights into the metabolic activity of the larvae [20].

4.3 Xenodiagnosis

A xenodiagnostic method using M. domestica has been described for the diagnosis of gastric habronemosis [11]. This involves feeding laboratory-reared flies on fecal samples from suspect horses and then examining the flies for L3 larvae after 10 to 14 days [11]. This method has a sensitivity of 80% and is particularly useful for detecting low-level infestations [11].

4.4 Serological and Biomarker Assays

Acute phase proteins (APPs), including serum amyloid A (SAA) and haptoglobin, are significantly elevated in horses with cutaneous habronemiasis [18]. Interleukin-6 (IL-6) and tumor necrosis factor-alpha (TNF-alpha) are also elevated, reflecting the systemic inflammatory response [18]. Nitric oxide (NO) and oxidative stress markers, such as malondialdehyde (MDA), are increased in affected horses, indicating a role for oxidative damage in the pathogenesis [18].

4.5 Histopathology

Histopathological examination of biopsy specimens is diagnostic for cutaneous habronemiasis [3]. The presence of L3 larvae within a granuloma, surrounded by eosinophilic debris and Splendore-Hoeppli material, is pathognomonic [3]. Immunohistochemistry using anti-Habronema polyclonal antibodies can confirm the presence of larval antigens in tissue sections [3].

5. Treatment and Management

5.1 Anthelmintic Therapy

Macrocyclic lactones, particularly ivermectin and moxidectin, are the mainstay of treatment for both gastric and cutaneous habronemiasis [11, 15]. Ivermectin (200 micrograms/kg) and moxidectin (400 micrograms/kg) are effective against adult and L4 stages [11]. Moxidectin has a longer residual activity and is preferred for use in areas with high fly pressure [11]. A single dose of ivermectin is effective for gastric habronemiasis, but cutaneous lesions may require two to three doses at 2-week intervals [15].

5.2 Topical and Surgical Management

For cutaneous lesions, surgical excision of the granulomatous tissue is often necessary [13, 15]. This is followed by topical application of a corticosteroid and antibiotic combination to reduce inflammation and prevent secondary infection [13]. Photodynamic therapy (PDT) using a photosensitizing agent and light source has been described as an alternative to surgical excision for small lesions [21].

5.3 Fly Control

Control of M. domestica is critical for preventing reinfection [9, 10]. This includes the use of fly traps, insecticidal sprays, and biological control agents such as Bacillus thuringiensis [9]. Stable hygiene, including prompt removal of manure, is essential to reduce fly breeding sites [9].

6. Differential Diagnosis

Cutaneous habronemiasis must be differentiated from other causes of proliferative dermatitis in horses, including:

• Pythiosis (Pythium insidiosum): Characterized by "kunkers" (necrotic masses) and a lack of response to ivermectin.
• Sarcoids: Viral-induced fibropapillomas, often non-pruritic.
• Equine eosinophilic granuloma: Idiopathic, non-parasitic, and responsive to corticosteroids.
• Bacterial granulomas: Caused by Staphylococcus or Rhodococcus species, often with a purulent exudate.

7. Epidemiology and Geographic Distribution

H. muscae is found worldwide, with high prevalence in tropical and subtropical regions [8, 16]. In a study of horses in Morocco, 60% of horses were infected with H. muscae [8]. In Kentucky, USA, a necropsy survey found H. muscae in 30% of thoroughbreds [6, 7]. In India, a study of Manipuri ponies found a 40% prevalence of cutaneous habronemiasis [16]. In Israel, molecular characterization of H. muscae from cutaneous lesions confirmed the species as the primary agent [14].

8. Public Health and Zoonotic Considerations

H. muscae is not considered a zoonotic pathogen. No cases of human infection have been reported. However, the parasite is a significant cause of morbidity in horses and can lead to economic losses due to treatment costs and reduced performance.

9. Conclusion

Habronema muscae is a significant equine parasite causing both gastric and cutaneous disease. Molecular diagnostics, including PCR and qPCR, have improved the accuracy of diagnosis and enabled species-specific identification. Treatment with macrocyclic lactones is effective, but control of the intermediate host, M. domestica, is essential for prevention. Further research into the molecular mechanisms of larval development and host-parasite interactions is needed to develop novel therapeutic strategies.

References

[1] Naem S. First description of the horse stomach worm, Habronema muscae (Spirurida: Habronematidae) by scanning electron microscopy. Parasitol Res. 2007.

[2] Rakhshandehroo E, Sharifiyazdi H, Shayegh H, et al. Molecular and morphological comparison of two different types of Habronema muscae (Nematoda: Habronematidae) in horse. Parasitol Res. 2014.

[3] Amininajafi F, Mehrara MR, Hosseini A, et al. Histopathological features of cutaneous and gastric habronemiasis in horse. J Parasit Dis. 2016.

[4] Traversa D, Giangaspero A, Galli P, et al. Specific identification of Habronema microstoma and Habronema muscae (Spirurida, Habronematidae) by PCR using markers in ribosomal DNA. Mol Cell Probes. 2004.

[5] Höglund J, Ljungström BL, Nilsson O, et al. Occurrence of Gasterophilus intestinalis and some parasitic nematodes of horses in Sweden. Acta Vet Scand. 1997.

[6] Lyons ET, Tolliver SC, Drudge JH, et al. Common internal parasites found in the stomach, large intestine, and cranial mesenteric artery of thoroughbreds in Kentucky at necropsy (1985 to 1986). Am J Vet Res. 1987.

[7] Lyons ET, Tolliver SC, Drudge JH, et al. Parasites in Kentucky Thoroughbreds at necropsy: emphasis on stomach worms and tapeworms. Am J Vet Res. 1983.

[8] Pandey VS, Ouhelli H, Elkhalfane A. Epidemiological observations on stomach worms of horses in Morocco. J Helminthol. 1981.

[9] Schuster RK, Sivakumar S. The larval development of Habronema muscae (Nematoda: Habronematidae) affects its intermediate host, Musca domestica (Diptera: Muscidae). Parasitol Res. 2017.

[10] Schuster RK, Sivakumar S, Kinne J, et al. Cutaneous and pulmonal habronemosis transmitted by Musca domestica in a stable in the United Arab Emirates. Vet Parasitol. 2010.

[11] Schuster RK, Sivakumar S. A xenodiagnostic method using Musca domestica for the diagnosis of gastric habronemosis and examining the anthelmintic efficacy of moxidectin. Vet Parasitol. 2013.

[12] Buzzell GR, Tariq S, Traversa D, et al. Morphology of the infective larval stage of the equid parasite Habronema muscae (Spirurida: Habronematidae), from houseflies (Musca domestica). Parasitol Res. 2011.

[13] Américo L, Aquino LPCT, Moura AB, et al. Cutaneous and conjunctival habronemosis in horses treated at the Veterinary Hospital of the Santa Catarina State University, Brazil. Rev Bras Parasitol Vet. 2024.

[14] Salant H, Rojas A, Yardeny D, et al. Cutaneous habronemosis in horses: First molecular characterization of Habronema muscae in Israel. Comp Immunol Microbiol Infect Dis. 2021.

[15] Pusterla N, Watson JL, Wilson WD, et al. Cutaneous and ocular habronemiasis in horses: 63 cases (1988-2002). J Am Vet Med Assoc. 2003. *** Disclaimer: This article is for educational and informational purposes only. It is not intended to substitute for professional veterinary advice, diagnosis, treatment, or regulatory guidance. Always consult a licensed veterinarian or qualified specialist regarding animal health, disease diagnosis, and therapeutic decisions.

[16] Devi CN, Borthakur SK, Patra G, et al. Incidence of cutaneous habronemosis in Manipuri ponies in India. Vet Parasitol Reg Stud Reports. 2019.

[17] Veado HC, Silva AS, Fagundes JLA, et al. Multiple Simultaneous Proliferative Lesions on the Prepuce and Penis of a Gelding. J Equine Vet Sci. 2021.

[18] El-Deeb W, Iacob O, Fayez M, et al. Acute phase proteins, interleukin-6, tumor necrosis factor, nitric oxide and oxidative stress markers in horses with cutaneous habronemosis under field condition. Vet Parasitol. 2018.

[19] Traversa D, Giangaspero A, Iorio R, et al. Semi-nested PCR for the specific detection of Habronema microstoma or Habronema muscae DNA in horse faeces. Parasitology. 2004.

[20] Salem MA, El-Gameel SM, Kamel MS, et al. Innovative diagnostic strategies for equine habronemiasis: exploring molecular identification, gene expression, and oxidative stress markers. Parasit Vectors. 2025.

[21] Ferreira I, Pinto JG, Oliveira EGL, et al. Photodynamic therapy in the treatment of cutaneous habronemosis in a horse: Case report. J Equine Vet Sci. 2025.

[22] Waddell AH. A survey of habronema spp and the identification of third-stage larvae of Habronema megastoma and Habronema muscae in secretion. Aust Vet J. 1969.

[23] White SD, Bourdeau PJ, Brément T, et al. Skin disease in donkeys (Equus asinus): a retrospective study from four veterinary schools. Vet Dermatol. 2019.

[24] Amininajafi F, Mehrara MR, Hosseini A, et al. Retraction Note to: Histopathological features of cutaneous and gastric habronemiasis in horse. J Parasit Dis. 2016.

[25] Myers DA, Smith CD, Greiner EC, et al. Cutaneous periocular Habronema infection in a dromedary camel (Camelus dromedarius). Vet Dermatol. 2010.